Dwight Barnes, OD
Optometrist · Cary, NCNPI 1306820188
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,050 of the $13,989 with a category attached, or 71.8%. Coopervision Inc. accounts for 87.9% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $7,098, more than ten times the $104 reported in 2019. Among optometrist clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 58 payments — averaging $241.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$12K
- Lumenis BE Inc$974
- Bausch & Lomb Americas Inc.$234
- Johnson & Johnson Vision Care, Inc.$176
- Alcon$101
- Bausch & Lomb, A Division Of Bausch Health US, LLC$77
- plus $131 from 5 others
Across 5 payments — averaging $2354.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Coopervision Inc.$12K
What the payments were for
- Consulting fees$5004%
- Speaking & faculty fees$10,05072%
- Travel & lodging$6805%
- Food & beverage$2,74420%
- Entertainment$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 35 | $12,297 |
| Lumenis BE Inc | 1 | $974 |
| Bausch & Lomb Americas Inc. | 5 | $234 |
| Johnson & Johnson Vision Care, Inc. | 5 | $176 |
| Alcon | 6 | $101 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $77 |
| Visioneering Technologies, Inc. | 1 | $50 |
| Tarsus Pharmaceuticals, Inc. | 1 | $27 |
| Biotissue Holdings Inc. | 1 | $20 |
| AbbVie | 1 | $19 |
| Optos, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MiSight Contact Lens$11,284
- optilight$974
- Paragon CRT$223
- Ortho-K Contact Lens$143
- INFUSE$125
- Acuvue$102
How this compares
$13,989 in reported general payments places this provider in the 95th percentile of 1,326 optometrist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 34 | $213 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Cary
- Michael SamuelsCary$13K
- Madison MossCary$12K
- Monica MaCary$9K
- Crystal BrimerWilmington$920K
- Osama SaidRaleigh$597K
- Ryan CorteAsheville$569K
- Sanjay PatelApex$518K
- Sean SmolenyakRaleigh$512K
- Rachael WrubleBelmont$228K
- Lisa GreeneArden$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.